NeoGenomics Inc. (NEO)
NeoGenomics Statistics
Share Statistics
NeoGenomics has 128.46M shares outstanding. The number of shares has increased by 0.59% in one year.
| Shares Outstanding | 128.46M |
| Shares Change (YoY) | 0.59% |
| Shares Change (QoQ) | 0.16% |
| Owned by Institutions (%) | 96.83% |
| Shares Floating | 126.92M |
| Failed to Deliver (FTD) Shares | 86 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 3.55M, so 2.77% of the outstanding shares have been sold short.
| Short Interest | 3.55M |
| Short % of Shares Out | 2.77% |
| Short % of Float | 2.8% |
| Short Ratio (days to cover) | 3.08 |
Valuation Ratios
The PE ratio is -26.51 and the forward PE ratio is 76.17. NeoGenomics's PEG ratio is 2.32.
| PE Ratio | -26.51 |
| Forward PE | 76.17 |
| PS Ratio | 3.16 |
| Forward PS | 1.2 |
| PB Ratio | 2.31 |
| P/FCF Ratio | -61.32 |
| PEG Ratio | 2.32 |
Enterprise Valuation
NeoGenomics Inc. has an Enterprise Value (EV) of 2.3B.
| EV / Earnings | -29.21 |
| EV / Sales | 3.48 |
| EV / EBITDA | -1522.05 |
| EV / EBIT | -24.97 |
| EV / FCF | -67.57 |
Financial Position
The company has a current ratio of 1.98, with a Debt / Equity ratio of 0.67.
| Current Ratio | 1.98 |
| Quick Ratio | 1.89 |
| Debt / Equity | 0.67 |
| Total Debt / Capitalization | 40.15 |
| Cash Flow / Debt | 0.01 |
| Interest Coverage | -13.92 |
Financial Efficiency
Return on equity (ROE) is -0.09% and return on capital (ROIC) is -6.11%.
| Return on Equity (ROE) | -0.09% |
| Return on Assets (ROA) | -0.05% |
| Return on Capital (ROIC) | -6.11% |
| Revenue Per Employee | $300,257.27 |
| Profits Per Employee | $-35,784.55 |
| Employee Count | 2,200 |
| Asset Turnover | 0.4 |
| Inventory Turnover | 13.85 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -37.96% in the last 52 weeks. The beta is 1.28, so NeoGenomics's price volatility has been higher than the market average.
| Beta | 1.28 |
| 52-Week Price Change | -37.96% |
| 50-Day Moving Average | 12.1 |
| 200-Day Moving Average | 14.58 |
| Relative Strength Index (RSI) | 38.8 |
| Average Volume (20 Days) | 1.39M |
Income Statement
In the last 12 months, NeoGenomics had revenue of 660.57M and earned -78.73M in profits. Earnings per share was -0.62.
| Revenue | 660.57M |
| Gross Profit | 290.1M |
| Operating Income | -92.11M |
| Net Income | -78.73M |
| EBITDA | -1.51M |
| EBIT | -92.11M |
| Earnings Per Share (EPS) | -0.62 |
Balance Sheet
The company has 367.01M in cash and 605.33M in debt, giving a net cash position of -238.32M.
| Cash & Cash Equivalents | 367.01M |
| Total Debt | 605.33M |
| Net Cash | -238.32M |
| Retained Earnings | -325.78M |
| Total Assets | 1.64B |
| Working Capital | 294.78M |
Cash Flow
In the last 12 months, operating cash flow was 7.02M and capital expenditures -41.06M, giving a free cash flow of -34.04M.
| Operating Cash Flow | 7.02M |
| Capital Expenditures | -41.06M |
| Free Cash Flow | -34.04M |
| FCF Per Share | -0.27 |
Margins
Gross margin is 43.92%, with operating and profit margins of -13.94% and -11.92%.
| Gross Margin | 43.92% |
| Operating Margin | -13.94% |
| Pretax Margin | -11.92% |
| Profit Margin | -11.92% |
| EBITDA Margin | -0.23% |
| EBIT Margin | -13.94% |
| FCF Margin | -5.15% |
Dividends & Yields
NEO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -6.57% |
| FCF Yield | -2.81% |
Analyst Forecast
The average price target for NEO is $18.5, which is 96.2% higher than the current price. The consensus rating is "Buy".
| Price Target | $18.5 |
| Price Target Difference | 96.2% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
Stock Splits
The last stock split was on Apr 16, 2003. It was a backward split with a ratio of 1:100.
| Last Split Date | Apr 16, 2003 |
| Split Type | backward |
| Split Ratio | 1:100 |
Scores
| Altman Z-Score | 1.53 |
| Piotroski F-Score | 4 |